You are here

Translation of Endovascular Treatment into Evidence-Based Practice

Drs Alberts and Jauch
Original Program Date:
October 12, 2015
Estimated Time: 1 hour 1 minute
Release Date: January 1, 2016

View Activity

CME for this activity is available January 1, 2016 – January 1, 2017.

This activity is jointly provided by Medical Education Resources and National Stroke Association.

Learning Goal

This program covers the translation of endovascular treatment into evidence-based practice and provide an explanation of endovascular treatment trials, clinical results and discusses new guidelines for acute care.

Learning Objectives

Through participation in this activity, learners will be able to:

  • Discuss recent endovascular stroke trials and results
  • Identify strengths and weaknesses of the trials
  • Translate the new guidelines into standards of acute stroke treatment

Target Audience

Translation of Endovascular Stroke Treatment into Evidence-Based Practice webinar is targeted at emergency medicine professionals including physicians, nurses, physicians’ assistants, and nurse practitioners—the professionals who are frequently on the front line for triage of potential stroke patients. This activity is also appropriate for neurologists and other stroke specialists who may have the opportunity to educate peers within their facility.

Physician Credit

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Education Resources (MER) and National Stroke Association. MER is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Medical Education Resources designates this activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate within the extent of their participation in the activity.

Nursing Credit

Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This CE activity provides 1 contact hour of continuing nursing education.

Medial Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1 contact hour.

For questions regarding this activity, please contact Medical Education Resources or National Stroke Association 


This activity is designed for individual participation and each individual must register for the event. For those seeking continuing education, post-test and evaluation forms must be completed in order to receive credit. These forms will be available to you immediately following your participation in the activity. All participants will also receive the required forms for completion within a week of their participation via email. It is the responsibility of the participant to return the completed forms to There are no fees for participation or receiving credit for this activity.

For those seeking continuing education credits, the following is required:

  • Read the learning objectives and faculty disclosures
  • View the educational activity.
  • After viewing the activity, complete the post-assessment evaluation.
  • Click on “Submit” to finishing the requirements to receive accreditation for this activity. 

A statement of credit will be issued only upon receipt of a completed evaluation form and post-test with a score of 70% or better. Statements of credit will be issued within 6 weeks.

If you are viewing this program as a group, contact us at for more information.

Content Developed and Presented By

Mark Alberts, MD, FAHA
Professor, Neurology and Neurotherapeutics
Vice Chair, Clinical Affairs; Department of Neurology and Neurotherapeutics
Medical Director, Neurology Service for UT Southwestern University Hospitals
UT Southwestern Medical Center

Edward Jauch, MD, MS, FAHA, FACEP
Professor, Interim Chief, Division of Emergency Medicine
Associate Vice Chair, Research
Department of Medicine Professor
Department of Neurosciences-Medical University of South Carolina Charleston, S.C

Disclosure of Conflict of Interest

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Faculty Disclosures

The faculty reported the following financial relationships with commercial interests who products or services may be mentioned in this CME activity.


Name of Faculty

Reported Financial Relationship

Mark Alberts, MD, FAHA

Research: Thrombosis Research Institute, Lundbeck
Speaker's Bureau: Boehringer-Ingelheim, Janssen, Bristol-Meyers Squibb, Pfizer, Genentech Inc., Chiesi
Consultant: Boehringer-Ingelheim, Janssen, Bristol-Meyers Squibb, Pfizer, Genentech, Merck, Daiichi-Sankyo  

Edward Jauch, MD, MS, FAHA, FACEP

Genentech Inc., Penumbra, Stryker, Medtronic, Inc.

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Content Managers

Reported Financial Relationship

Denise Taylor, National Stroke Association

No financial relationships to disclose

MER content managers

No financial relationships to disclose


The content and views presented in this education activity are those of the speakers and do not necessarily reflect those of Medical Education Resources, National Stroke Association and/or Genenetech, INC. The speakers have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications or other course of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacture’s product information, and comparison with recommendations of other authorizes. The information presented in this activity is not meant to serve as a guideline for patient management.

MER’s Privacy Policy

Translation of Endovascular Stroke Treatment into Evidence-Based Practice is supported by an educational grant from Stryker.

Find a Support Group


Get Involved


For over 30 years we have been the trusted source for free resources and education to the stroke community. Together, we empower survivors and their circle of care to thrive after stroke. Make your tax-deductible donation today to support the growing needs of the stroke community.